SVF in knee osteoarthritis: placebo-controlled trial
Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial
The American journal of sports medicine
Findings: WOMAC symptom scores improved more in the SVF groups than with placebo through 12 months.
Points to consider: Small sample; MRI showed no change in cartilage thickness. Read alongside the larger MILES trial, which used different methods and comparators.
Device & relevance: The processing method in this study has not been matched to SONICSTEM; it is not direct evidence for the Cellabsys device.